跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Mazdutide
首页
药物
Mazdutide
Mazdutide
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
USE OF MAZDUTIDE
EP 4360641 A1
申请人: INNOVENT BIOLOGICS SUZHOU CO LTD
优先权: 2021
CN
EP
US
WO
4 件公开
TREATMENT METHOD USING MAZDUTIDE
EP 4534095 A4
申请人: INNOVENT BIOLOGICS SUZHOU CO LTD
优先权: 2022
CN
EP
US
WO
4 件公开
INTERMEDIATE FOR PREPARING GLUCAGON AND GLP-1 DUAL AGONIST AND PREPARATION METHOD THEREFOR
EP 4805381 A1
申请人: INNOVENT BIOLOGICS SUZHOU CO LTD
优先权: 2023
CN
EP
WO
3 件公开
METHODS OF TREATING DIABETES AND OBESITY
EP 4788362 A1
申请人: INNOVENT BIOLOGICS SUZHOU CO LTD
优先权: 2023
EP
WO
2 件公开
METHODS OF TREATING ADOLESCENT OBESITY
EP 4788356 A1
申请人: INNOVENT BIOLOGICS SUZHOU CO LTD
优先权: 2023
EP
WO
2 件公开
METHODS OF TREATING SUBJECTS HAVING DIABETES AND OBESITY
WO 2026129636 A1
申请人: INNOVENT BIOLOGICS SUZHOU CO LTD
优先权: 2024
WO
2 件公开
COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES WITH TOPICAL-LINGUAL RECEPTOR AGONISTS
WO 2025208093 A1
申请人: GILA THERAPEUTICS INC
优先权: 2024
WO
NEW GLP-1 RECEPTOR AGONISTS FOR THE TREATMENT OF JOINT DISEASES
WO 2025219601 A1
申请人: 4MOVING BIOTECH
优先权: 2024
WO
METHOD OF TREATING POLYCYSTIC OVARY SYNDROME
WO 2026002224 A1
申请人: INNOVENT BIOLOGICS SUZHOU CO LTD
优先权: 2024
WO
METHODS OF TREATING SUBJECTS HAVING HEART FAILURE
WO 2026138742 A1
申请人: INNOVENT BIOLOGICS SUZHOU CO LTD
优先权: 2024
WO
药物
反馈